Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0002081359-26-000005

Options or other derivatives

  • Chief Scientific Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lerner Lorena Raquel · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-24 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X05/form4-02262026_040210.xml…